The Neurobiology of Alzheimer’s Disease

  • Peter Davies
Part of the Advances in Behavioral Biology book series (ABBI, volume 38A)


It is not possible in the space permitted to provide anything like a complete overview of the neurobiology of Alzheimer’s Disease. I will thus simply attempt to identify the key questions raised by recent advances in this field. A much more comprehensive review of recent developments in selected areas of this research was recently published in Neurobiology of Aging (1).


Neurofibrillary Tangle Amyloid Deposition Amyloid Plaque Alzheimer Brain Senile Plaque 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alzheimer’s Disease: Current and Emerging Topics on Age-Related Neurodegeneration. Neurobiol. Aging 10, 383: 1989.CrossRefGoogle Scholar
  2. 2.
    Dickson, D.W., Farlo, J., Davies, P., Crystal, H., Fuld, P. and Yen, S.-H.: Alzheimer’s Disease: a double-labelling immunohistochemical study of senile plaques. Am. J. Path. 132, 86: 1988.PubMedGoogle Scholar
  3. 3.
    Glenner, G.G. and Wong, C.W.: Alzheimer’s Disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Comm. 120: 884, 1984.CrossRefGoogle Scholar
  4. 4.
    Goldgaber, D., Lerman, M.I., McBride, O.W., Safafioti, U. and Gajdusek, D.C.: Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer’s Disease. Science 235: 877, 1986.CrossRefGoogle Scholar
  5. 5.
    Kang, J., Lemarie, H-G., Unterbeck, A., Salbaum, J.M., Masters, C., Grzeschik, K-H., Multhaup, G., Beyreuther, K. and Muller-Hill, B.: The precursor of Alzheimer’s Disease amyloid A4 protein resembles a cell surface receptor. Nature 325: 733, 1986.CrossRefGoogle Scholar
  6. 6.
    Kitaguchi, N., Takahashi, Y., Tokushima, Y., Shiojiri, S. and Hirataki, I.: Novel precursor of Alzheimer’s Disease amyloid protein shows protease inhibitory activity. Nature 331: 530–532, 1988.PubMedCrossRefGoogle Scholar
  7. 7.
    Ponte, P., Gonzalez-DeWhitt, P., Schilling, J., Miller, J., Hsu, D., Greenberg, B., Davis, K.L., Wallace, W., Lieberberg, I., Fuller, F. and Cordell, B.: A new A4 amyloid mRNA contains a domain homologous to serine protease inhibitors. Nature 331: 525, 1988.PubMedCrossRefGoogle Scholar
  8. 8.
    Tanzi, R., McClatchey, A.I., Lamperti, E.D., BillaKomaroff, L., Gusella, J.F. and Neve, R.L.: Protease inhibitor domain encoded by an amyloid precursor mRNA associated with Alzheimer’s Disease. Nature 331: 528, 1988.PubMedCrossRefGoogle Scholar
  9. 9.
    Oltersdorf, T., Fritz, L.C., Schenk, D.B., Lieberberg, I., Johnson-Wood, K.L., Beattie, E.C., Ward, P.J., Blacher, R.W., Dovey, H.F. and Sinha, S.: The secreted form of the Alzheimer’s amyloid precursor protein with the Kunitz domain is protease nexin II. Nature 341: 144, 1989.PubMedCrossRefGoogle Scholar
  10. 10.
    Davies, L., Wolska, B., Hilbich, C., Multhaup, G., Martins, R., Simms, G., Beyreuther, K. and Masters, C.L.: A4 amyloid protein deposition and the diagnosis of Alzheimer’s Disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurol. 38: 1688, 1988.CrossRefGoogle Scholar
  11. 11.
    Ikeda, S-I, Allsop, D. and Glenner, G.G.: Morphology and distribution of plaque and related deposits in the brains of Alzheimer’s Disease and control cases. Lab. Invest. 60: 133–122, 1989.Google Scholar
  12. 12.
    Wolozin, B.L., Pruchnicki, A., Dickson, D.W. and Davies, P.: A neuronal antigen in the brains of patients with Alzheimer’s disease. Science 232: 648–650, 1986.PubMedCrossRefGoogle Scholar
  13. 13.
    Katzman, R., Terry, R.D., DeTeresa, R., Brown, T., Davies, P., Fuld, P., Renbing, X. and Peck, A.: Clinical, pathological and neurochemical changes in dementia: A subciroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23: 138, 1988.PubMedCrossRefGoogle Scholar
  14. 14.
    Tomlinson, B.E., Blessed, G. and Roth, M.: Observations on the brains of non-demented old people. J. Neurol. Sci. 7: 331, 1968.PubMedCrossRefGoogle Scholar
  15. 15.
    Crystal, H., Dickson, D.W., Fuld, P., Masur, D., Scott, R., Mehler, M., Masdeu, J., Kawas, C., Aronson, M. and Wolfson, L.I.: Clinicopathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer’s Disease. Neurol. 38: 1682, 1988.CrossRefGoogle Scholar
  16. 16.
    Joachim, C.L., Mori, H. and Selkoe, D.J.: Amyloid beta-protein deposition in tissues other than the brain in Alzheimer’s Disease. Nature 341: 226, 1989.PubMedCrossRefGoogle Scholar
  17. 17.
    Tabadon, J., Mandybur, T.I, Perry, G., AutiloGambetti, L., Gambetti, P.: The widespread alteration of neurites in Alzheimer’s Disease may be unrelated to amyloid deposition. J. Neuropath. Exp. Neurol. 48: 340, 1989.CrossRefGoogle Scholar
  18. 18.
    Hyman, B.T., Van Hoesen, G.T., Wolozin, B.L, Davies, P., Kromer, L.J. and Damasio, A.R.: Alz-50 antibody recognizes Alzheimer-related neuronal changes. Ann. Neurol. 23: 371, 1988.PubMedCrossRefGoogle Scholar
  19. 19.
    Goldman, J.E. and Yen, S.-H.: Cytoskeletal protein abnormalities in neurodegenerative diseases. Ann. Neurol. 19: 209, 1986.PubMedCrossRefGoogle Scholar
  20. 20.
    Davies, P.: A critical review of the role of the cholinergic system in human cognition. Ann. NY Acad. Sci. 444: 212, 1985.PubMedCrossRefGoogle Scholar
  21. 21.
    Tabaton, M., Whitehouse, P.J., Perry, G., Davies, P., Autilio-Gambetti, L. and Gambetti, P.: Alz-50 recognizes abnormal filaments in Alzheimer’s Disease and progressive supranuclear palsy. Ann. Neurol. 24: 407, 1988.PubMedCrossRefGoogle Scholar
  22. 22.
    Wolozin, B.L., Scicutella, A. and Davies, P.: Re-expression developmentally restricted antigen in Alzheimer’s Disease and Down’s Syndrome. PNAS (USA) 16: 6202, 1988.CrossRefGoogle Scholar
  23. 23.
    Ksiezak-Reding, H., Davies, P. and Yen, S.-H.: Alz 50, a monoclonal antibody to Alzheimer’s disease antigen, cross-reacts with tau proteins from bovine and normal human brain. J. Biol. Chem. 263: 7943, 1988.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Peter Davies
    • 1
  1. 1.Departments of Pathology and NeuroscienceAlbert Einstein College of MedicineBronxUSA

Personalised recommendations